Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis

This study has been completed.
Information provided by (Responsible Party):
Centocor, Inc. Identifier:
First received: December 22, 2005
Last updated: November 3, 2014
Last verified: November 2014